253930 War and Public Health: A 20-Year Perspective

Monday, October 31, 2011: 12:30 PM

Barry S. Levy, MD, MPH , Adjunct Professor of Public Health, Tufts University School of Medicine, Sherborn, MA
Victor W. Sidel, MD , Professor of Social Medicine, Albert Einstein Medical College, Montifiore Medical Center, Bronx, New York, NY
Since 1991, there have been significant developments pertaining to armed conflict and the roles of public health workers in addressing the health and human rights issues related to armed conflict. This session will address the following six issues and their evolution during this 20-year period: the impact of non-state actors in an asymmetric world after the end of the Cold War; the increases in the arms trade and military expenditures; the U.S. "war on terror" response to the 2001 terrorist attacks; the increasing likelihood of resource wars over water and petroleum; the continuing impact of armed conflict on non-combatant civilians; and the evolution of new threats, from the use of unarmed drones in conflict to the prospect of cyber attacks.

Learning Areas:
Diversity and culture
Ethics, professional and legal requirements
Public health or related laws, regulations, standards, or guidelines
Public health or related public policy
Public health or related research
Social and behavioral sciences

Learning Objectives:
Describe issues related to war and public health over the last 20 years. 2. Describe the roles of public health workers in addressing issues related to war, terrorism, and public health.

Keywords: War, Public Health

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: For more than 50 years, I have written and spoken extensively, performed research, and written book chapters and edited books on the adverse effects of war, including the adverse effects on communities.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.